share_log

Edgewell Personal Care Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Edgewell Personal Care Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Edgewell個人護理公司剛剛超出了收益預期:以下是分析師認爲接下來會發生的事情
Simply Wall St ·  05/11 21:14

It's been a good week for Edgewell Personal Care Company (NYSE:EPC) shareholders, because the company has just released its latest second-quarter results, and the shares gained 5.7% to US$39.97. The result was positive overall - although revenues of US$599m were in line with what the analysts predicted, Edgewell Personal Care surprised by delivering a statutory profit of US$0.72 per share, modestly greater than expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

對於Edgewell個人護理公司(紐約證券交易所代碼:EPC)的股東來說,這是美好的一週,因爲該公司剛剛發佈了最新的第二季度業績,股價上漲了5.7%,至39.97美元。總體業績是積極的——儘管收入爲5.99億美元,與分析師的預測一致,但Edgewell Personal Care驚訝地實現了每股0.72美元的法定利潤,略高於預期。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。考慮到這一點,我們收集了最新的法定預測,以了解分析師對明年的預期。

earnings-and-revenue-growth
NYSE:EPC Earnings and Revenue Growth May 11th 2024
紐約證券交易所:EPC收益和收入增長 2024年5月11日

Following last week's earnings report, Edgewell Personal Care's six analysts are forecasting 2024 revenues to be US$2.29b, approximately in line with the last 12 months. Statutory per-share earnings are expected to be US$2.51, roughly flat on the last 12 months. In the lead-up to this report, the analysts had been modelling revenues of US$2.31b and earnings per share (EPS) of US$2.58 in 2024. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a small dip in their earnings per share forecasts.

繼上週的業績之後,Edgewell Personal Care的六位分析師預測2024年的收入爲22.9億美元,與過去12個月大致持平。法定每股收益預計爲2.51美元,與過去12個月基本持平。在本報告發布之前,分析師一直在模擬2024年的收入爲23.1億美元,每股收益(EPS)爲2.58美元。因此,在最近的業績公佈之後,整體情緒似乎略有下降——收入估計沒有重大變化,但分析師的每股收益預測確實略有下降。

It might be a surprise to learn that the consensus price target was broadly unchanged at US$43.43, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Edgewell Personal Care at US$53.00 per share, while the most bearish prices it at US$35.00. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

得知共識目標股價基本維持在43.43美元,這可能會令人驚訝,分析師明確表示,預期的收益下降預計不會對估值產生太大影響。但是,還有另一種思考價格目標的方法,那就是研究分析師提出的價格目標範圍,因爲範圍廣泛的估計可能表明,對業務可能的結果有不同的看法。目前,最看漲的分析師對Edgewell個人護理的估值爲每股53.00美元,而最看跌的分析師估值爲35.00美元。這表明估值仍然存在一點差異,但分析師似乎對該股的看法並不完全分歧,好像這可能是成功或失敗一樣。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The period to the end of 2024 brings more of the same, according to the analysts, with revenue forecast to display 1.8% growth on an annualised basis. That is in line with its 1.8% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 6.9% per year. So although Edgewell Personal Care is expected to maintain its revenue growth rate, it's forecast to grow slower than the wider industry.

從現在的大局來看,我們可以理解這些預測的方法之一是看看它們如何與過去的業績和行業增長預期相比較。分析師表示,截至2024年底將帶來更多相同的情況,收入按年計算預計將增長1.8%。這與其在過去五年中1.8%的年增長率一致。相比之下,我們的數據表明,預計類似行業的其他公司(有分析師報道)的收入每年將增長6.9%。因此,儘管預計Edgewell個人護理將保持其收入增長率,但預計其增長速度將低於整個行業。

The Bottom Line

底線

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Edgewell Personal Care. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at US$43.43, with the latest estimates not enough to have an impact on their price targets.

最大的擔憂是,分析師下調了每股收益預期,這表明Edgewell Personal Care可能會面臨業務不利因素。從好的方面來看,收入估計沒有重大變化;儘管預測表明它們的表現將比整個行業差。共識目標股價穩定在43.43美元,最新估計不足以對其目標價格產生影響。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Edgewell Personal Care going out to 2026, and you can see them free on our platform here.

話雖如此,公司收益的長期軌跡比明年重要得多。我們對Edgewell個人護理的預測將持續到2026年,你可以在我們的平台上免費查看。

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Edgewell Personal Care that you should be aware of.

別忘了可能仍然存在風險。例如,我們已經確定了你應該注意的 Edgewell 個人護理的 1 個警告標誌。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論